AVTX Avalo Therapeutics
Avalo Therapeutics earnings company data as of 1:41 PM ET 11/17
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | -0.55 | -0.34 | Beat |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by AVTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $52K sold by 1 insider outside a trading plan
- $8.3M sold by 4 insiders under 10b5-1 plans
-
Christopher Ryan Sullivan CFOPlanned sale$202K 12,394 shares at $16.33 24% of stakeTraded Sep 16 Filed Sep 18
-
Christopher Ryan Sullivan CFOPlanned sale$179K 10,185 shares at $17.62 20% of stakeTraded Sep 10 Filed Sep 11
-
Mittie Doyle Chief Medical OfficerPlanned sale$14K 679 shares at $20.00 1.3% of stakeTraded Aug 28 Filed Sep 1
-
Mittie Doyle Chief Medical OfficerPlanned sale$20K 1,000 shares at $20.00 1.9% of stakeTraded Aug 17 Filed Aug 19
-
Christopher Ryan Sullivan CFOPlanned sale$1.5M 72,725 shares at $19.94 65% of stakeTraded Aug 17–18 Filed Aug 19
-
Jennifer Riley Chief Strategy OfficerSale$52K 2,655 shares at $19.59 6.7% of stakeTraded Aug 11 Filed Aug 12
-
Mittie Doyle Chief Medical OfficerPlanned sale$14K 679 shares at $20.00 1.3% of stakeTraded Aug 10 Filed Aug 12
-
Mittie Doyle Chief Medical OfficerPlanned sale$20K 1,000 shares at $20.00 1.9% of stakeTraded Jul 27 Filed Jul 29
-
Mittie Doyle Chief Medical OfficerPlanned sale$93K 4,654 shares at $20.00 8.2% of stakeTraded Jun 30 Filed Jul 2
-
Mittie Doyle Chief Medical OfficerPlanned sale$26K 1,450 shares at $18.00 2.7% of stakeTraded Jun 23 Filed Jun 25
-
Mittie Doyle Chief Medical OfficerPlanned sale$11K 679 shares at $16.00 1.4% of stakeTraded May 28 Filed Jun 1
-
Mittie Doyle Chief Medical OfficerPlanned sale$56K 3,000 shares at $18.76 45% of stakeTraded May 15 Filed May 19
-
Christopher Ryan Sullivan CFOPlanned sale$449K 18,606 shares at $24.12 98% of stakeTraded May 7 Filed May 11
-
Mittie Doyle Chief Medical OfficerPlanned sale$2.2M 108,234 shares at $20.61 97% of stakeTraded May 5–6 Filed May 7
-
Christopher Ryan Sullivan CFOPlanned sale$949K 47,000 shares at $20.19 99% of stakeTraded May 6 Filed May 7
Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 10 share withholdings for taxes, and 5 stock grants.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,1.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 424B3 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon